Original research: These are detailed studies reporting original research in which telemedicine has played a significant role. They include hypothesis, background study, methods, results, interpretation of findings, and a discussion of possible implications. Original research articles have a word count of up to 2500.
Review article: Review articles give an overview of existing literature, with emphasis on telemedicine, often identifying specific problems or issues and analyzing information from available published work on the topic with a balanced perspective. Review articles can be of three types: literature reviews, systematic reviews, and meta-analyses. Review articles have the maximum word limit of up to 3000.
Clinical case study: Clinical case studies present the details of real patient cases from medical or clinical practice in which telemedicine played a significant role. The cases presented are usually those that contribute significantly to the existing knowledge on the field. The study is expected to discuss signs, symptoms, diagnosis, and treatment of a disease. The word count is up to 1500.
Clinical trial: Clinical trials describe the methodology, implementation, and results of controlled studies in which telemedicine played a significant role. Word count is 2500.
Peer review policy
All manuscripts submitted for publication undergo peer review.
Publication fees will be $750.00 US and payable for CME and non-CME feature articles upon acceptance. We have waived this fee in our first year of publication.
CRITERIA FOR PUBLICATION
TMT applies rigorous editorial and peer review overseen by a team of professional editors and independent editor experts in the field.
Within the scope of the journal, as noted above, manuscripts should represent:
· Originality and practicality in advancing telehealth and telemedicine
· Importance to research, practice, or change in the field
· Interest and relevance for those outside the audience
· Rigorous methodology, with conclusions justified by the evidence presented
· Adherence to the highest ethical standards
To submit a new manuscript, please send your submission to the Managing Editor, John Russo Jr., PharmD, email@example.com.